Newsletters

newsletters

Weekly Mass Torts Bulletin 2023-September-18

According to recently disclosed data, the amount of prescription opioid tablets transported into the United States in the second half of the 2010s fell significantly, even as the overdose epidemic in the country grew worse.

Weekly Mass Torts Bulletin 2023-September-11

Manufacturer of chemicals and consumer goods 3M said that it has agreed to pay $6 billion to resolve claims filed by U.S. military members that the company's defective earplugs caused them to suffer hearing loss or other severe ailments.

Weekly Mass Torts Bulletin 2023-August-28

Indivior has agreed to pay $30 million to resolve a class action lawsuit brought by health plans against the pharmaceutical company for allegedly improperly stifling generic competition for its Suboxone opioid addiction therapy.

Weekly Mass Torts Bulletin 2023-August-21

The results of a recent study state that long-term adverse effects of Nexium, Prilosec, and other proton pump inhibitor (PPI) treatments may increase the risk of dementia.

Weekly Mass Torts Bulletin 2023-August-14

A scheme to avoid paying more than $1 billion as part of a federal settlement for victims of the opioid crisis is being floated by one of the big pharmaceutical corporations that has been charged with flooding America with cheap, addictive pills.

Weekly Mass Torts Bulletin 2023-August-7

Teva Pharmaceutical Industries Ltd. has agreed to resolve accusations that its marketing of opioid medications increased the operational expenses of U.S. hospitals by up to $126 million over 18 years.

Weekly Mass Torts Bulletin 2023-July-24

Federal regulators have announced a warning label update over Horizon Pharmaceuticals' Tepezza which may cause severe and permanent hearing damage.

Weekly Mass Torts Bulletin 2023-July-17

At the Riverfront Convention Centre, the Craven County Board of Commissioners conducted a special meeting to discuss the opioid settlement funds and Memorandum of Agreement (MOA).